The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The Economic Burden of Elevated Blood Glucose Levels in 2012: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes
Open accessAbstract
OBJECTIVE: To update estimates of the economic burden of undiagnosed diabetes, prediabetes, and gestational diabetes mellitus in 2012 in the U.S. and to present state-level estimates. Combined with published estimates for diagnosed diabetes, these statistics provide a detailed picture of the economic costs associated with elevated glucose levels. RESEARCH DESIGN AND METHODS: This study estimated health care use and medical expenditures in excess of expected levels occurring in the absence of diabetes or prediabetes. Data sources that were analyzed include Optum medical claims for ∼4.9 million commercially insured patients who were continuously enrolled from 2010 to 2012, Medicare Standard Analytical Files containing medical claims for ∼2.6 million Medicare patients in 2011, and the 2010 Nationwide Inpatient Sample containing ∼7.8 million hospital discharge records. The indirect economic burden includes reduced labor force participation, missed workdays, and reduced productivity. State-level estimates reflect geographic variation in prevalence, risk factors, and prices. RESULTS: The economic burden associated with diagnosed diabetes (all ages) and undiagnosed diabetes, gestational diabetes, and prediabetes (adults) exceeded $322 billion in 2012, consisting of $244 billion in excess medical costs and $78 billion in reduced productivity. Combined, this amounts to an economic burden exceeding $1,000 for each American in 2012. This national estimate is 48% higher than the $218 billion estimate for 2007. The burden per case averaged $10,970 for diagnosed diabetes, $5,800 for gestational diabetes, $4,030 for undiagnosed diabetes, and $510 for prediabetes. CONCLUSIONS: These statistics underscore the importance of finding ways to reduce the burden of prediabetes and diabetes through prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309
The Increasing Prevalence of Diabetes in Pregnancy
Hunt, K. J., & Schuller, K. L. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.03.002 · Cited by 500
Collins, G. S., Mallett, S., Omar, O., & Yu, L.-M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-103 · Cited by 484
A review of adjusted estimators of attributable risk
Benichou, J. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000303 · Cited by 440
Projecting the Future Diabetes Population Size and Related Costs for the U.S.
Huang, E. S., Basu, A., O'Grady, M., & Capretta, J. C. (2009) · Diabetes Care · doi:10.2337/dc09-0459 · Cited by 414
Development and validation of a patient self-assessment score for diabetes risk
Bang, H., Edwards, A. M., Bomback, A. S., Ballantyne, C. M., Brillon, D., Callahan, M. A., Teutsch, S. M., Mushlin, A. I., & Kern, L. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-11-200912010-00005 · Cited by 333
Research works printed but not linked: 1
- Centers for Disease Control and Prevention (CDC), 2010, National Health and Nutrition Examination Survey Data
Cited by
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1774 · Cited by 1,024
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 945
Epidemiology of type 2 diabetes in India
Pradeepa, R., & Mohan, V. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1627_21 · Cited by 606
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
Metadata
- Authors
- Dall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F.
- Affiliations
- IHS Life Sciences, Washington, DC
- Lewin Group (United States) (US)
- Novo Nordisk Inc., Plainsboro, NJ
- Corresponding author
- Dall, Timothy M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-11-08
- Volume
- 37
- Issue
- 12
- Pages
- 3172-3179
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6702607
- OpenAlex
- W2116695875
- Semantic Scholar
- 300145783a82f2462489ef450df27475352d5ca7
- Cited by
- 382
- References
- 23
- Citations by year
- 2026: 15 · 2025: 13 · 2024: 26 · 2023: 36 · 2022: 32 · 2021: 52 · 2020: 41 · 2019: 36 · 2018: 29 · 2017: 32 · 2016: 38 · 2015: 29 · 2014: 3
- FWCI
- 27.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- economic burden of diabetes, undiagnosed diabetes, prediabetes, gestational diabetes mellitus, hyperglycemia, health care costs, productivity loss, labor force participation
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Prediabetic State, Pregnancy, United States, Prevalence, Diabetes, Gestational, Health Care Costs, Young Adult, Delayed Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Economic Burden of Elevated Blood Glucose Levels in 2012: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes. https://app.cochat.ai/papers/10.2337/dc14-1036
- The paper
- Dall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F. (2014). The Economic Burden of Elevated Blood Glucose Levels in 2012: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes. Diabetes Care. https://doi.org/10.2337/dc14-1036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.